This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
By This Author:
Page 3 of 10

What Financial Jitters? I'm Buying Lifelock

By Bill Gunderson

Identity theft protection is a growing business and that's Lifelock's bread and butter.

06:30AM 01/30/14

Contrarian Investing Led Me to Salix Pharmaceuticals

By Bill Gunderson

If this company can stay on its current trajectory it has nearly 92% upside potential.

10:42AM 01/24/14

Actavis Leads the Way

By Bill Gunderson

This generic drug maker is just what the investor ordered.

10:21AM 01/17/14

Colfax: One of the Few Industrial Sector Winners

By Bill Gunderson

This quiet, industrial worker bee may not be in a popular sector but it makes money.

09:21AM 01/16/14

Old Dominion Freight Just Keeps on Trucking

By Bill Gunderson

This company continues to prove it can deliver for shareholders.

06:30AM 01/09/14

Valeant Is Having a Healthy Run

By Bill Gunderson

Pharma stocks are hot and this one could be the next Pfizer.

06:30AM 01/03/14

LKQ Is in the Fast Lane to Profits

By Bill Gunderson

This 'junk yard' stock is a $10 billion large-cap company and it's doing very well, thank you.

06:30AM 12/23/13

Anacor Pharmaceuticals Is Not for Everyone

By Bill Gunderson

This stock isn't for widows and orphans. It's for an aggressive portfolio.

06:00AM 12/19/13

DexComm Is a Healthy Choice

By Bill Gunderson

This stock has yet to turn a profit but it's already a winner for Bill Gunderson.

07:00AM 12/13/13

Pentair Cleans Up

By Bill Gunderson

This water stock passes Bill Gunderson's filtering system.

06:15AM 12/06/13

Page 3 of 10

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV


DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs